Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
ID: 329395Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering administrative supplements to existing NIH grants and cooperative agreements to address unforeseen cost increases within the scope of approved awards. These supplements aim to support research projects that may require additional funding due to unexpected expenses, while ensuring alignment with NIH mission goals. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, for-profit entities, and tribal governments. Applications must be submitted electronically via Grants.gov and will undergo an administrative review focusing on budget justification and potential impact on the parent award. The opportunity is open until January 24, 2025, and interested parties can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for assistance or further information.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through various NIH institutes, is offering administrative supplements to existing NIH grants and cooperative agreements aimed at addressing unforeseen cost increases. These supplements are designed to support research projects where additional funds may be required yet remain within the original project scope. Eligible applicants include various organizations, including higher education institutions, nonprofits, for-profit entities, and tribal governments, provided the research aligns with NIH mission goals. Applications must adhere to NIH guidelines and be submitted electronically via Grants.gov. The NIH will conduct an administrative review of submissions, focusing on the justification for the budget and the potential impact on the parent award. Key dates and registration requirements underline the process's importance. This funding opportunity reissues the previous notice PA-18-591, now expiring on January 24, 2025, reinforcing the NIH's commitment to supporting diverse research initiatives amid evolving financial needs.
    Similar Opportunities
    Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced an urgent funding opportunity for competitive revisions to existing research grants aimed at addressing immediate public health crises. This initiative allows Principal Investigators holding specific NIH grants to apply for additional funding to meet unforeseen needs related to public health emergencies, with applications routed directly to the relevant NIH awarding component. The program emphasizes support for diverse institutions, including historically underrepresented entities, and aims to enhance research capacity in critical health areas. Interested applicants can find more details and submit inquiries via grantsinfo@nih.gov, with proposals due by October 25, 2025, under the funding opportunity announcement PA-23-044.
    AHRQ Administrative Supplements for Grants in Health Services Research
    Active
    Agency for Health Care Research and Quality
    The Agency for Healthcare Research and Quality (AHRQ) has announced a Notice of Funding Opportunity (NOFO) for administrative supplements to active AHRQ grants, aimed at addressing unforeseen increased costs associated with approved health services research projects. Eligible applicants, including public and state-controlled institutions of higher education, must hold active AHRQ awards and adhere to specific budget limits, which are capped at 20% of federal direct costs or $100,000 for larger grants, and 10% for smaller projects. This funding opportunity is crucial for supporting ongoing research that enhances healthcare quality and accessibility, particularly for priority populations. Interested parties should submit applications electronically via Grants.gov by the deadlines of June 26, October 26, and February 26 annually, with inquiries directed to GrantQueries@ahrq.hhs.gov.
    Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Supplements to Promote Diversity in Health-Related Research," aimed at enhancing diversity within the health research workforce. This initiative seeks to recruit and support individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and those from disadvantaged backgrounds, while providing necessary accommodations for researchers with disabilities. The funding, which can reach up to $500,000, is available for administrative supplements to existing research grants, with applications undergoing administrative review rather than peer review. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov, with the application deadline set for May 7, 2026.
    Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced an Emergency Competitive Revision program aimed at providing funding for applications related to disasters declared under the Stafford Act or public health emergencies. This initiative is designed to support existing NIH awards and facilitate projects that address urgent public health issues stemming from such emergencies. Eligible applicants include a diverse range of organizations, such as higher education institutions, nonprofits, and local governments, particularly those impacted by recent disasters. The funding opportunity, designated as PA-24-201, opens on April 19, 2024, with applications due by April 18, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PA-24-201.html.
    Administrative Supplements to Promote Diversity in Research and Development Small Businesses SBIR/STTR (Admin Supp Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC), is offering administrative supplements aimed at enhancing diversity within the research and entrepreneurial workforce supported by Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants. This funding opportunity is designed to recruit, mentor, and support individuals from underrepresented backgrounds and those with disabilities, facilitating their involvement in ongoing research projects without leading independent clinical trials. The initiative emphasizes the importance of diverse perspectives in advancing health-related research and professional development, with eligible applicants including small businesses and various research candidates. Interested parties should note that the application deadline is October 13, 2027, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PA-24-255.html.
    Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced an Administrative Supplement funding opportunity aimed at enhancing cancer disparities research through the initiative PAR-22-114. This program encourages collaborations between seasoned cancer researchers and those focused on cancer disparities, with the goal of addressing adverse differences in cancer outcomes among racial/ethnic minorities and underserved populations. The funding supports the expansion of existing NCI-funded research projects to include feasibility studies on various cancer types, with a total funding amount of $2.55 million available for up to 10 awards, each with a budget limit of $150,000 in direct costs over a 12-month period. Interested applicants must submit their proposals by January 23, 2025, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC), has announced the Innovation Corps (I-Corps) at NIH Program, aimed at enhancing the commercialization of biomedical innovations from Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase I projects. This program provides administrative supplement awards to eligible small business concerns, facilitating entrepreneurship training and assisting teams in refining their commercialization strategies through customer discovery activities over an eight-week course. With a total funding pool of up to $2.64 million available for up to 48 awards, individual grants are capped at $55,000, and applications must be submitted by January 31, 2025. Interested applicants are encouraged to contact NIH Grants Information at grantsinfo@nih.gov for further guidance before applying.
    Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for competing revisions to existing Single Project Research Grants and Cooperative Agreements, with the option for clinical trials. This initiative allows NIH award recipients to apply for additional funds to expand their current projects within the relevant Institutes and Centers, specifically in response to Notices of Special Interest (NOSI) issued by participating NIH entities. The funding opportunity, identified as PA-23-317, is open to a wide range of eligible applicants, including higher education institutions, nonprofit organizations, and foreign entities, reflecting NIH's commitment to advancing impactful health research. Applications must be submitted by November 24, 2026, through the NIH ASSIST system or Grants.gov, and will be evaluated based on scientific merit and adherence to specified criteria. For further information, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for organizations seeking to change the recipient organization of specific NIH grants. This initiative allows eligible applicants, including higher education institutions, nonprofits, and various government entities, to submit applications for the transfer of grant awards, ensuring continuity in research projects. While the submission of applications does not guarantee approval for the transfer, the NIH encourages coordination with relevant institutes and adherence to grant policies to facilitate a smooth transition. Interested parties can find more information and submit inquiries via email at grantsinfo@nih.gov, with key submission dates starting from July 12, 2024, and the opportunity closing on July 12, 2027.
    Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for organizations holding specific types of NIH grants to submit applications for changes in recipient organization status, known as Successor-in-Interest. This initiative aims to facilitate transitions for organizations while ensuring project continuity, allowing eligible applicants—including various higher education institutions, nonprofits, government entities, and foreign organizations—to propose research that aligns with the original NIH-supported project scope. Applications will undergo an administrative evaluation focusing on compliance with federal regulations, with key dates including an open submission period starting July 19, 2024, and a funding expiration date set for July 18, 2027. Interested parties can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.